AnalystsDaniel BusbyDaniel Busby's Stock Forecasts
AnalystsDaniel Busby
Analyst Ranking
Bottom 22%
#2733 out of 3462 analysts
Average Return
-7.1%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good
Daniel Busby's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verrica Pharmaceuticals IncVRCA | +5.90% | $11.70 | $12.39 | 2021-05-13 - 2021-10-18 | Buy |
Daniel Busby's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Endo International plcENDP | 1 | Hold | $5.00 | +20.19% | Maintains | 2 months ago |
Agile Therapeutics IncAGRX | 1 | Buy | $5.00 | +463.70% | Maintains | 3 months ago |
Pfizer IncPFE | 1 | Hold | $44.00 | +6.49% | Maintains | 4 months ago |
Verrica Pharmaceuticals IncVRCA | 1 | Buy | $19.00 | +53.35% | Initiates Coverage On | 5 months ago |
Mannkind CorpMNKD | 1 | Hold | $5.00 | +20.19% | Initiates Coverage On | 5 months ago |
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.